Analyst Ratings for ResMed (RMD)
RMD Rating Summary
RMD Price Target Summary
- Highest: $345.00 (UBS)
- Lowest: $180.00 (Wolfe Research)
- Average: $242.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$242.00 (+21.6%)
* Over Last 12-Mos
Rating Score: 4.4 / 10
Percentile Rank: 44%
Avg. $ Target:
$242.00 (+21.6%)
* Over Last 12-Mos
Rating Score: 4.4 / 10
Percentile Rank: 44%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/16/2026 | RBC Capital | Craig Wong-Pan | Downgrade | Sector Perform (Outperform) |
234.00 (N/A) |
198.57 (198.99) |
0.21% | Details |
| 7/13/2026 | Citi | Laura Sutcliffe | Downgrade | Neutral (Buy) |
235.00 (270.00) |
208.45 (198.99) |
-4.54% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
